On Friday, Neuronetics Inc (NASDAQ: STIM) opened lower -3.85% from the last session, before settling in for the closing price of $0.78. Price fluctuations for STIM have ranged from $0.66 to $5.07 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 7.39% annually for the last half of the decade. Company’s average yearly earnings per share was noted 16.36% at the time writing. With a float of $27.25 million, this company’s outstanding shares have now reached $29.09 million.
In an organization with 203 employees, it is important to assess its efficiency.
Neuronetics Inc (STIM) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Neuronetics Inc is 10.07%, while institutional ownership is 53.03%. The most recent insider transaction that took place on Sep 12 ’24, was worth 75,000. In this transaction Director of this company bought 100,000 shares at a rate of $0.75, taking the stock ownership to the 453,098 shares. Before that another transaction happened on Sep 05 ’24, when Company’s Director bought 25,000 for $0.80, making the entire transaction worth $20,000. This insider now owns 289,818 shares in total.
Neuronetics Inc (STIM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 16.36% per share during the next fiscal year.
Neuronetics Inc (NASDAQ: STIM) Trading Performance Indicators
Check out the current performance indicators for Neuronetics Inc (STIM). In the past quarter, the stock posted a quick ratio of 2.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.32.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.10, a number that is poised to hit -0.23 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Neuronetics Inc (STIM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.59 million. That was better than the volume of 0.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 13.37%. Additionally, its Average True Range was 0.10.
During the past 100 days, Neuronetics Inc’s (STIM) raw stochastic average was set at 2.94%, which indicates a significant decrease from 8.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 101.90% in the past 14 days, which was lower than the 165.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1829, while its 200-day Moving Average is $2.5567. However, in the short run, Neuronetics Inc’s stock first resistance to watch stands at $0.8120. Second resistance stands at $0.8739. The third major resistance level sits at $0.9179. If the price goes on to break the first support level at $0.7061, it is likely to go to the next support level at $0.6621. The third support level lies at $0.6002 if the price breaches the second support level.
Neuronetics Inc (NASDAQ: STIM) Key Stats
There are currently 29,998K shares outstanding in the company with a market cap of 22.73 million. Presently, the company’s annual sales total 71,350 K according to its annual income of -30,190 K. Last quarter, the company’s sales amounted to 16,450 K and its income totaled -9,830 K.
